|
Age-based assessment of cell-free DNA genomic profiles in metastatic castration-resistant prostate cancer (mCRPC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - CSL Limited; Mesoblast; Oncosil |
|
|
Patents, Royalties, Other Intellectual Property - I am listed in a 'Rewards to Inventors' Scheme with the Institute of Cancer Research London Enterprise Unit as part of a research project I was involved in working at the Institute of Cancer Research London (in collaboration with Astex Therapeutics (now A |
|
|
Research Funding - Mundipharma |
|
|
Honoraria - Medscape; Onclive |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Predicine |
|
|
No Relationships to Disclose |
|
|
Employment - Connected Medical Solutions (I) |
Leadership - Connected Medical Solutions (I) |
Stock and Other Ownership Interests - Connected Medical Solutions (I); Imagion Biosystems |
Consulting or Advisory Role - Imagion Biosystems |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag; Pfizer |
|
|
Honoraria - Advanced Accelerator Applications |
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Genapsys |
Travel, Accommodations, Expenses - Celgene |
|
|
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar |
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis |
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst) |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar |
|
|
Honoraria - Astellas Pharma; Ipsen; Janssen; Research Review |
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer; Roche |
|
|
|
|
Stock and Other Ownership Interests - Predicine |